https://www.has-sante.fr/jcms/p_3218744/fr/idelvion 2020 false false false France insurance, health, reimbursement treatment outcome albutrepenonacog alfa coagulation factor IX hemorrhage hemorrhage hemophilia B evaluation of the transparency committee factor IX recombinant fusion proteins serum albumin